This article is more than 5 years old. Information may no longer be current.
CV death decline slowing in US
Click Here to Manage Email Alerts
New data highlight a deceleration in the decline of all CVD, heart disease and stroke mortality rates since 2011 in the United States.
Stephen Sidney, MD, MPH, director of research clinics and senior research scientist at Kaiser Permanente Northern California Division of Research, and colleagues analyzed data from the CDC Wide-Ranging Online Data for Epidemiologic Research system to determine national trends in age-adjusted mortality rates due to all CVD, heart disease, stroke and cancer from 2000 to 2011 and from 2011 to 2014.
According to the report, the rate of decline of CVD, heart disease and stroke mortality slowed after 2011, while the rate of decline of cancer mortality remained stable:
- The annual rate of decline for CVD mortality was 3.79% in 2000 to 2011 vs. 0.65% in 2011 to 2014.
- The annual rate of decline for heart disease mortality was 3.69% in 2000 to 2011 vs. 0.76% in 2011 to 2014.
- The annual rate of decline for stroke mortality was 4.53% in 2000 to 2011 vs. 0.37% in 2011 to 2014.
- The annual rate of decline for cancer mortality was 1.49% in 2000 to 2011 vs. 1.55% in 2011 to 2014.
Age-adjusted rates of all CVD mortality declined from 341.3 in 2000 to 219.9 in 2014 (3.56% rate decline), heart disease mortality declined from 257.6 in 2000 to 167 in 2014 (35.2% rate decline) and stroke mortality declined from 60.9 in 2000 to 36.5 in 2014 (40.1% rate decline).
The decline in all CVD mortality rates occurred in men, women and all races/ethnicities during the study period. The annual rate of decline for total CVD mortality for men was 3.69% in 2000 to 2011 vs. 0.23% in 2011 to 2014, while the annual rate of decline for total CVD mortality for women was 3.98% in 2000 to 2011 vs. 1.17% in 2011 to 2014.
“Given the high absolute burden and associated costs of heart disease and stroke, continued vigilance and innovation are essential in our efforts to address the ongoing challenge of CVD prevention,” Sidney and colleagues wrote in JAMA Cardiology. “However, the recent deceleration in the rate of decline in heart disease mortality is alarming and warrants expanded innovative efforts to improve population level CVD prevention.” – by Dave Quaile
Disclosure: The researchers report no relevant financial disclosures.
Click Here to Manage Email Alerts